Mechanisms of T cell activation: Integrating signaling pathways, experimental models, and therapeutic implications

T cell activation is a central mechanism in adaptive immunity, modulating immune surveillance, host defense, and immune-mediated pathology. It is a highly coordinated mechanism including antigen recognition, co-stimulatory and co-inhibitory signaling, and cytokine-mediated regulation. This work aims to synthesize existing knowledge on the molecular mechanisms modulating T cell activation, with emphasis on integrated signaling cascades, experimental models, and therapeutic implications. A narrative review of the literature was conducted, focusing on key signaling cascades, regulatory mechanisms, and experimental methods used to analyze T cell activation in both basic and translational immunology. T cell activation is orchestrated via the mediation of T cell receptor (TCR) signaling with co-stimulatory and co-inhibitory cascades, alongside cytokine-mediated cues that collectively determine T cell fate and function. Critical intracellular signaling cascades, offer pivotal function in transcriptional and metabolic reprogramming. Experimental models such as in vitro stimulation systems, flow cytometry-based analyses, and advanced imaging approaches have significantly improved mechanistic knowledge of T cell responses. These insights have informed therapeutic approaches targeting T cell activation in cancer immunotherapy, autoimmune diseases, and infectious conditions. Although, obstacles in clinical translation remain. A comprehensive understanding of T cell activation needs integration of molecular, experimental, and clinical perspectives. Importantly, this review emphasizes the comparative strengths and limitations of contemporary experimental models and discusses how multi-omics integration and computational modeling can improve reproducibility, physiological relevance, and translational predictability in T cell research. Advancements in this field continue to offer opportunities for the development of targeted immunotherapies and enhanced disease intervention approaches. See also the graphical abstract(Fig. 1).